Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?Padhmanand Sudhakar, Judith Wellens, Bram Verstockt, Marc Ferrante, João Sabino, Séverine Vermeire
28 September 2022
Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel diseaseJordi Rimola, Joana Torres, Shankar Kumar, Stuart A Taylor, Torsten Kucharzik
4 August 2022
COVID-19 and liver diseaseJean-François Dufour, Thomas Marjot, Chiara Becchetti, Herbert Tilg
14 June 2022
Current therapies and new developments in NASHJean-François Dufour, Quentin M Anstee, Elisabetta Bugianesi, Stephen Harrison, Rohit Loomba, Valerie Paradis, Herbert Tilg, Vincent Wai-Sun Wong, Shira Zelber-sagi
16 June 2022
Artificial intelligence in gastroenterology and hepatology: how to advance clinical practice while ensuring health equityEugenia Uche-Anya, Adjoa Anyane-Yeboa, Tyler M Berzin, Marzyeh Ghassemi, Folasade P May
10 June 2022
Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemicSimeng Lin, Louis HS Lau, Neil Chanchlani, Nicholas A Kennedy, Siew C Ng
27 April 2022
Cross-roads for meta-analysis and network meta-analysis of H. pylori therapyDavid Y Graham, Ruben Hernaez, Theodore Rokkas
8 November 2021
What to do about the leaky gutMichael Camilleri, Adrian Vella
11 September 2021
Novel therapeutic targets for cholestatic and fatty liver diseaseMichael Trauner, Claudia Daniela Fuchs
6 October 2021
Dietary fibres and IBS: translating functional characteristics to clinical value in the era of personalised medicineDaniel So, Peter R Gibson, Jane G Muir, Chu K Yao
20 August 2021